🔎 Trials Near Me

홈 › 난소암 › 뉴욕 › New York City

NY New York City의 난소암 임상 시험

난소암 관련 연구 69개가 New York City 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

피험자 모집 중1/2상
  • Research Site, New York
  • Research Site, New York
18세 ~ 130세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05417594

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

피험자 모집 중2/3상
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07001748

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

피험자 모집 중
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT04751435

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

피험자 모집 중2상
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
전 연령 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

피험자 모집 중1상
  • Mount Sinai, New York
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06840886

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

피험자 모집 중1상
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • 외 2개
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

피험자 모집 중1/2상
  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

피험자 모집 중2상
  • Memorial Sloan Kettering Hospital, New York
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

피험자 모집 중
  • Mount Sinai Health System, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05287451

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

피험자 모집 중1상
  • Research Site, New York
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Study of AVZO-021 in Patients With Advanced Solid Tumors

피험자 모집 중1/2상
  • Avenzo Therapeutics Recruiting Site, New York
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

피험자 모집 중관찰 연구
  • NYU Langone Medical Center, New York
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

피험자 모집 중1/2상
  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT03564340

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 여성 · 2026. 9. 24. 업데이트됨 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

피험자 모집 중3상
  • Laura and Isaac Perlmutter Cancer Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

피험자 모집 중1상
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

피험자 모집 중2상
  • Columbia University Medical Center /ID# 277990, New York
18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07059845

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

피험자 모집 중1/2상
  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center Head Neck Services, New York
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT04752826

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

피험자 모집 중3상
  • Memorial Sloan Kettering Cancer Center ( Site 0072), New York
18세 이상 · 여성 · 2026. 9. 17. 업데이트됨 · NCT07318558

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

피험자 모집 중2상
  • Laura and Isaac Perlmutter Cancer Center, New York
18세 ~ 99세 · 여성 · 2026. 9. 15. 업데이트됨 · NCT07023627

A Study of Isoquercetin in People With Ovarian Cancer

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07303894

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

피험자 모집 중1/2상
  • Mount Sinai, New York
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06303505

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

피험자 모집 중3상
  • Columbia University Medical Center, New York
18세 이상 · 여성 · 2026. 9. 14. 업데이트됨 · NCT04575935

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

피험자 모집 중1상
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

피험자 모집 중1상
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06400472

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

피험자 모집 중3상
  • Laura and Isaac Perlmutter Cancer Center ( Site 0076), New York
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT06824467

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

피험자 모집 중1/2상
  • Start Nyli, New York
18세 이상 · 여성 · 2026. 9. 1. 업데이트됨 · NCT07736937

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07186842

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

피험자 모집 중1상
  • New York Cancer & Blood Specialists, New York
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06582017

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

피험자 모집 중1상
  • Icahn School of Medicine at Mount Sinai, New York
15세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

피험자 모집 중1/2상
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07470853

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 8. 13. 업데이트됨 · NCT05985655

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

피험자 모집 중1상
  • Xencor Investigative Site, New York
18세 이상 · 여성 · 2026. 8. 13. 업데이트됨 · NCT07593092

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

피험자 모집 중1/2상
  • Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York
18세 이상 · 여성 · 2026. 8. 13. 업데이트됨 · NCT06040970

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

피험자 모집 중
  • Mount Sinai Chelsea, New York
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Mount Sinai West, New York
  • 외 4개
35세 ~ 50세 · 여성 · 2026. 8. 7. 업데이트됨 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

피험자 모집 중3상
  • Mount Sinai Chelsea, New York
  • Bellevue Hospital Center, New York
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • 외 3개
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06580314

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

피험자 모집 중1/2상
  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06330064

Clinical Pre-screening Protocol for Ovarian Cancer

피험자 모집 중관찰 연구
  • The Blavatnik Family-Chelsea Medical Center at Mount Sinai, New York
18세 이상 · 여성 · 2026. 7. 30. 업데이트됨 · NCT03877796

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

피험자 모집 중2/3상
  • NYU Langone Health, New York
18세 이상 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT06161025

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

피험자 모집 중2상
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • Investigative Site #103, New York
  • Investigative Site #106, New York
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06545942

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

피험자 모집 중3상
  • Mount Sinai, New York
18세 이상 · 여성 · 2026. 7. 14. 업데이트됨 · NCT05804370

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

피험자 모집 중1/2상
  • Mt Sinai Hospital, New York
18세 ~ 75세 · 여성 · 2026. 7. 13. 업데이트됨 · NCT07322094

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT06695845

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

피험자 모집 중1상
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
  • Columbia University Irving Medical Center, New York
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

피험자 모집 중3상
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
18세 이상 · 여성 · 2026. 7. 2. 업데이트됨 · NCT06819007

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

피험자 모집 중
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 여성 · 2026. 7. 1. 업데이트됨 · NCT05429970

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

피험자 모집 중1/2상
  • New York University Langone Health, New York
  • ICHAN School of Medicine at Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

피험자 모집 중1/2상
  • NYU Langone Medical Center, New York
18세 이상 · 모든 성별 · 2026. 6. 12. 업데이트됨 · NCT06051695

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT04300556

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

피험자 모집 중2상
  • USA04-0, New York
18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06953089

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT03686124

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

피험자 모집 중3상
  • Memorial Sloan-Kettering Cancer Center, New York
18세 이상 · 여성 · 2026. 4. 16. 업데이트됨 · NCT05659381

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

피험자 모집 중1상
  • Site 0173, New York
18세 이상 · 여성 · 2026. 4. 7. 업데이트됨 · NCT04516447

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

피험자 모집 중
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
25세 ~ 50세 · 여성 · 2026. 4. 6. 업데이트됨 · NCT04294927

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center (All protocol activities), New York
18세 이상 · 모든 성별 · 2026. 4. 1. 업데이트됨 · NCT06290193

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

피험자 모집 중1/2상
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06395519

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT05103683

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

피험자 모집 중1상
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 2. 11. 업데이트됨 · NCT06623396

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

피험자 모집 중1상
  • NYU Cancer Institute Clinical Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 1. 14. 업데이트됨 · NCT06234423

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

피험자 모집 중관찰 연구
  • Massive Bio SYNERGY-AI site, New York
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

피험자 모집 중1상
  • Exelixis Clinical Site #5, New York
18세 이상 · 모든 성별 · 2025. 9. 5. 업데이트됨 · NCT05932862

NYSCF Scientific Discovery Biobank

피험자 모집 중관찰 연구
  • New York Stem Cell Foundation Research Institute, New York
30 Days · 모든 성별 · 2025. 3. 3. 업데이트됨 · NCT06203106

Comprehensive Outcomes for After Cancer Health

피험자 모집 중건강한 지원자 환영
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2024. 12. 11. 업데이트됨 · NCT05349227

다른 도시의 난소암 시험

New York City의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.